{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Parkinson\u2019s disease", "herbal extracts", "nanoformulations", "nanoparticles", "neurodegenerative disorders"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32318551", "DateRevised": {"Year": "2023", "Month": "11", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "04", "Day": "07"}], "Language": ["eng"], "ELocationID": ["238", "10.3389/fbioe.2020.00238"], "Journal": {"ISSN": "2296-4185", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in bioengineering and biotechnology", "ISOAbbreviation": "Front Bioeng Biotechnol"}, "ArticleTitle": "Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders.", "Pagination": {"StartPage": "238", "MedlinePgn": "238"}, "Abstract": {"AbstractText": ["Nanotechnology is one of the methods that influenced human life in different ways and is a substantial approach that assists to overcome the multiple limitations of various diseases, particularly neurodegenerative disorders (NDs). Diverse nanostructures such as polymer nanoparticles, lipid nanoparticles, nanoliposomes, nano-micelles, and carbon nanotubes (CNTs); as well as different vehicle systems including poly lactic-co-glycolic acid, lactoferrin, and polybutylcyanoacrylate could significantly increase the effectiveness, reduce the side effects, enhance the stability, and improve the pharmacokinetics of many drugs. NDs belong to a group of annoying and debilitating diseases that involve millions of people worldwide. Previous studies revealed that several nanoformulations from a number of natural products such as curcumin (Cur), quercetin (QC), resveratrol (RSV), piperine (PIP), <i>Ginkgo biloba</i>, and <i>Nigella sativa</i> significantly improved the condition of patients diagnosed with NDs. Drug delivery to the central nervous system (CNS) has several limitations, in which the blood brain barrier (BBB) is the main drawback for treatment of NDs. This review discusses the effects of herbal-based nanoformulations, their advantages and disadvantages, to manage NDs. In summary, we conclude that herbal-based nano systems have promising proficiency in treatment of NDs, either alone or in combination with other drugs."], "CopyrightInformation": "Copyright \u00a9 2020 Moradi, Momtaz, Bayrami, Farzaei and Abdollahi."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}, {"Identifier": [], "Affiliation": "Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Moradi", "ForeName": "Seyed Zachariah", "Initials": "SZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Bayrami", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}, {"Identifier": [], "Affiliation": "Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Abdollahi", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Bioeng Biotechnol", "NlmUniqueID": "101632513", "ISSNLinking": "2296-4185"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aalinkeel R., Kutscher H. L., Singh A., Cwiklinski K., Khechen N., Schwartz S. A., et al. (2018). Neuroprotective effects of a biodegradable poly (lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer\u2019s disease? J. Drug Target. 26 182\u2013193. 10.1080/1061186x.2017.1354002", "ArticleIdList": ["10.1080/1061186x.2017.1354002", "28697660"]}, {"Citation": "Abhinav K., Stanton B., Johnston C., Hardstaff J., Orrell R., Howard R., et al. (2007). Amyotrophic lateral sclerosis in South-East England: a population-based study. Neuroepidemiology 29 44\u201348.", "ArticleIdList": ["17898523"]}, {"Citation": "Ahmadi M., Agah E., Nafissi S., Jaafari M. R., Harirchian M. H., Sarraf P., et al. (2018). Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. Neurotherapeutics 15 430\u2013438. 10.1007/s13311-018-0606-7", "ArticleIdList": ["10.1007/s13311-018-0606-7", "PMC5935637", "29352425"]}, {"Citation": "Alam S., Khan Z. I., Mustafa G., Kumar M., Islam F., Bhatnagar A., et al. (2012). Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study. Intern. J. Nanomed. 7 5705\u20135718. 10.2147/IJN.S35329", "ArticleIdList": ["10.2147/IJN.S35329", "PMC3497894", "23180965"]}, {"Citation": "Ali T., Kim M. J., Rehman S. U., Ahmad A., Kim M. O. (2017). Anthocyanin-loaded PEG-gold nanoparticles enhanced the neuroprotection of anthocyanins in an A\u03b2 1\u201342 mouse model of Alzheimer\u2019s disease. Mol. Neurobiol. 54 6490\u20136506. 10.1007/s12035-016-0136-4", "ArticleIdList": ["10.1007/s12035-016-0136-4", "27730512"]}, {"Citation": "Aluani D., Tzankova V., Yordanov Y., Kondeva-Burdina M., Yoncheva K. J. B., Equipment B. (2017). In vitro protective effects of encapsulated quercetin in neuronal models of oxidative stress injury. Biotechnol. Biotechnol. Equip. 31 1055\u20131063. 10.1080/13102818.2017.1347523", "ArticleIdList": ["10.1080/13102818.2017.1347523"]}, {"Citation": "Alzheimer\u2019s and Dementia (2019). 2019 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 15 321\u2013387. 10.1016/j.jalz.2019.01.010", "ArticleIdList": ["10.1016/j.jalz.2019.01.010"]}, {"Citation": "Aras A., Guven M., Akman T., Ozkan A., Sen H., Duz U., et al. (2015). Neuroprotective effects of daidzein on focal cerebral ischemia injury in rats. Neural Regen. Res. 10 146\u2013152. 10.4103/1673-5374.150724", "ArticleIdList": ["10.4103/1673-5374.150724", "PMC4357099", "25788936"]}, {"Citation": "Aryani A., Denecke B. (2016). Exosomes as a nanodelivery system: a key to the future of neuromedicine? Mol. Neurobiol. 53 818\u2013834. 10.1007/s12035-014-9054-5", "ArticleIdList": ["10.1007/s12035-014-9054-5", "PMC4752585", "25502465"]}, {"Citation": "Barreca D., Bellocco E., D\u2019onofrio G., Nabavi S. F., Daglia M., Rastrelli L., et al. (2016). Neuroprotective effects of quercetin: from chemistry to medicine. CNS Neurol. Disord. Drug Targets 15 964\u2013975. 10.2174/1871527315666160813175406", "ArticleIdList": ["10.2174/1871527315666160813175406", "27528470"]}, {"Citation": "Bateman R. J., Xiong C., Benzinger T. L., Fagan A. M., Goate A., Fox N. C., et al. (2012). Clinical and biomarker changes in dominantly inherited alzheimer\u2019s disease. N. Engl. J. Med. 367 795\u2013804.", "ArticleIdList": ["PMC3474597", "22784036"]}, {"Citation": "Bates G. P., Dorsey R., Gusella J. F., Hayden M. R., Kay C., Leavitt B. R., et al. (2015). Huntington disease. Nat. Rev. Dis. Primers 1:15005. 10.1038/nrdp.2015.5", "ArticleIdList": ["10.1038/nrdp.2015.5", "27188817"]}, {"Citation": "Beaulieu J.-M., Gainetdinov R. R. (2011). The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63 182\u2013217. 10.1124/pr.110.002642", "ArticleIdList": ["10.1124/pr.110.002642", "21303898"]}, {"Citation": "Bengmark S. J. J. O. P., Nutrition E. (2006). Curcumin, an atoxic antioxidant and natural NF\u03baB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J. Parenter. Enteral. Nutr. 30 45\u201351. 10.1177/014860710603000145", "ArticleIdList": ["10.1177/014860710603000145", "16387899"]}, {"Citation": "Bhaskar S., Tian F., Stoeger T., Kreyling W., De La Fuente J. M., Graz\u00fa V., et al. (2010). Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Particle Fibre Toxicol. 7:3. 10.1186/1743-8977-7-3", "ArticleIdList": ["10.1186/1743-8977-7-3", "PMC2847536", "20199661"]}, {"Citation": "Binyamin O., Larush L., Frid K., Keller G., Friedman-Levi Y., Ovadia H., et al. (2015). Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant. Int. J. Nanomed. 10:7165. 10.2147/IJN.S92704", "ArticleIdList": ["10.2147/IJN.S92704", "PMC4664546", "26648720"]}, {"Citation": "Biradar S. M., Joshi H., Tarak K. C. (2013). Cerebroprotective effect of isolated harmine alkaloids extracts of seeds of Peganum harmala L. on sodium nitrite-induced hypoxia and ethanol-induced neurodegeneration in young mice. Pak. J. Biol. Sci. 16 1687\u20131697. 10.3923/pjbs.2013.1687.1697", "ArticleIdList": ["10.3923/pjbs.2013.1687.1697", "24506035"]}, {"Citation": "Bollimpelli V. S., Kumar P., Kumari S., Kondapi A. K. J. N. I. (2016). Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity. Neurochem. Intern. 95 37\u201345. 10.1016/j.neuint.2016.01.006", "ArticleIdList": ["10.1016/j.neuint.2016.01.006", "26826319"]}, {"Citation": "Bondi M., Montana G., Craparo E., Picone P., Capuano G., Carlo M., et al. (2009). Ferulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimer\u2019s disease: preparation, characterization and cytotoxicity studies. Curr. Nanosci. 5 26\u201332. 10.2174/157341309787314656", "ArticleIdList": ["10.2174/157341309787314656"]}, {"Citation": "Boroushaki M. T., Mollazadeh H., Afshari R. A. (2016). Pomegranate seed oil: a comprehensive review on its therapeutic effects. Intern. J. Pharm. Sci. Res. 7:430."}, {"Citation": "Braak H., Del Tredici K., R\u00fcb U., De Vos R. A., Steur E. N. J., Braak E. (2003). Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24 197\u2013211. 10.1016/s0197-4580(02)00065-9", "ArticleIdList": ["10.1016/s0197-4580(02)00065-9", "12498954"]}, {"Citation": "Brahmkhatri V. P., Sharma N., Sunanda P., D\u2019souza A., Raghothama S., Atreya H. S. (2018). Curcumin nanoconjugate Inhibits aggregation of N-terminal region (A\u03b2-16) of an amyloid beta peptide. N. J. Chem. 42 19881\u201319892. 10.1039/c8nj03541e", "ArticleIdList": ["10.1039/c8nj03541e"]}, {"Citation": "Caruso G., Caffo M., Alafaci C., Raudino G., Cafarella D., Lucerna S., et al. (2011). Could nanoparticle systems have a role in the treatment of cerebral gliomas? Nanomed. Nanotechnol. Biol. Med. 7 744\u2013752. 10.1016/j.nano.2011.02.008", "ArticleIdList": ["10.1016/j.nano.2011.02.008", "21419873"]}, {"Citation": "Chakraborty S., Stalin S., Das N., Choudhury S. T., Ghosh S., Swarnakar S. J. B. (2012). The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat. Biomaterial 33 2991\u20133001. 10.1016/j.biomaterials.2011.12.037", "ArticleIdList": ["10.1016/j.biomaterials.2011.12.037", "22257724"]}, {"Citation": "Chaudhuri K. R., Schapira A. H. (2009). Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 8 464\u2013474. 10.1016/s1474-4422(09)70068-7", "ArticleIdList": ["10.1016/s1474-4422(09)70068-7", "19375664"]}, {"Citation": "Chen X., Pan W. (2014). The treatment strategies for neurodegenerative diseases by integrative medicine. Integr. Med. Intern. 1 223\u2013225. 10.1159/000381546", "ArticleIdList": ["10.1159/000381546"]}, {"Citation": "Cheng K. K., Yeung C. F., Ho S. W., Chow S. F., Chow A. H. L., Baum L. J. T. (2013). Highly stabilized Curcumin nanoparticles tested in an in vitro blood\u2013brain barrier model and in alzheimer\u2019s disease Tg2576 mice. AAPS J. 15 324\u2013336. 10.1208/s12248-012-9444-4", "ArticleIdList": ["10.1208/s12248-012-9444-4", "PMC3675736", "23229335"]}, {"Citation": "Chonpathompikunlert P., Wattanathorn J., Muchimapura S. (2010). Piperine, the main alkaloid of thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer\u2019s disease. Food Chem. Toxicol. 48 798\u2013802. 10.1016/j.fct.2009.12.009", "ArticleIdList": ["10.1016/j.fct.2009.12.009", "20034530"]}, {"Citation": "Cirmi S., Ferlazzo N., Lombardo G. E., Ventura-Spagnolo E., Gangemi S., Calapai G., et al. (2016). Neurodegenerative diseases: might citrus flavonoids play a protective role? Molecules 21:312.", "ArticleIdList": ["PMC6274333", "27706034"]}, {"Citation": "Da Rocha Lindner G., Bonfanti Santos D., Colle D., Gasnhar Moreira E. L., Daniel Prediger R., Farina M., et al. (2015). Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly (lactide) nanoparticles in MPTP-induced Parkinsonism. Intern. J. Pharm. Sci. Res. 10 1127\u20131138. 10.2217/nnm.14.165", "ArticleIdList": ["10.2217/nnm.14.165", "25929569"]}, {"Citation": "Dahiya S., Rani R., Dhingra D., Kumar S., Dilbaghi N. J. F. (2018). Potentiation of nootropic activity of EGCG loaded nanosuspension by piperine in swiss male albino mice. Science 4 296\u2013302. 10.1016/j.fjps.2018.10.005", "ArticleIdList": ["10.1016/j.fjps.2018.10.005"]}, {"Citation": "Davatgaran-Taghipour Y., Masoomzadeh S., Farzaei M. H., Bahramsoltani R., Karimi-Soureh Z., Rahimi R., et al. (2017). Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective. Intern. J. Nanomed. 12:2689. 10.2147/IJN.S131973", "ArticleIdList": ["10.2147/IJN.S131973", "PMC5388197", "28435252"]}, {"Citation": "David M. A., Tayebi M. (2014). Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients. Front. Neurol. 5:251. 10.3389/fneur.2014.00251", "ArticleIdList": ["10.3389/fneur.2014.00251", "PMC4252634", "25520699"]}, {"Citation": "De Paula V. D. J. R., Guimar\u00e3es F. M., Diniz B. S., Forlenza O. V. (2009). Neurobiological pathways to Alzheimer\u2019s disease: Amyloid-beta, TAU protein or both? Dement. Neuropsychol. 3 188\u2013194. 10.1590/s1980-57642009dn30300003", "ArticleIdList": ["10.1590/s1980-57642009dn30300003", "PMC5618972", "29213627"]}, {"Citation": "Del Prado-Audelo M. L., Caballero-Flor\u00e1n I. H., Meza-Toledo J. A., Mendoza-Mu\u00f1oz N., Gonz\u00e1lez-Torres M., Flor\u00e1n B., et al. (2019). Formulations of Curcumin Nanoparticles for Brain Diseases. Biomolecules 9:56. 10.3390/biom9020056", "ArticleIdList": ["10.3390/biom9020056", "PMC6406762", "30743984"]}, {"Citation": "Del Tredici K., Braak H. (2012). Lewy pathology and neurodegeneration in premotor Parkinson\u2019s disease. Mov. Disord. 27 597\u2013607. 10.1002/mds.24921", "ArticleIdList": ["10.1002/mds.24921", "22508278"]}, {"Citation": "Demaagd G., Philip A. (2015). Parkinson\u2019s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. Pharm. Therap. 40:504.", "ArticleIdList": ["PMC4517533", "26236139"]}, {"Citation": "Deng X. Y., Li H. Y., Chen J. J., Li R. P., Qu R., Fu Q., et al. (2015). Thymol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice. Behav. Brain Res. 291 12\u201319. 10.1016/j.bbr.2015.04.052", "ArticleIdList": ["10.1016/j.bbr.2015.04.052", "25958231"]}, {"Citation": "Desai A. K., Grossberg G. T. (2005). Diagnosis and treatment of Alzheimer\u2019s disease. Neurology 64 S34\u2013S39.", "ArticleIdList": ["15994222"]}, {"Citation": "Dhawan S., Kapil R., Singh B. (2011). Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J. Pharm. Pharmacol. 63 342\u2013351. 10.1111/j.2042-7158.2010.01225.x", "ArticleIdList": ["10.1111/j.2042-7158.2010.01225.x", "21749381"]}, {"Citation": "Dolati S., Aghebati-Maleki L., Ahmadi M., Marofi F., Babaloo Z., Ayramloo H., et al. (2018a). Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial. JPP 233 5222\u20135230. 10.1002/jcp.26301", "ArticleIdList": ["10.1002/jcp.26301", "29194612"]}, {"Citation": "Dolati S., Ahmadi M., Aghebti-Maleki L., Nikmaram A., Marofi F., Rikhtegar R., et al. (2018b). Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators. Pharmacol. Rep. 70 1158\u20131167. 10.1016/j.pharep.2018.05.008", "ArticleIdList": ["10.1016/j.pharep.2018.05.008", "30340096"]}, {"Citation": "Dolati S., Babaloo Z., Ayromlou H., Ahmadi M., Rikhtegar R., Rostamzadeh D., et al. (2019). Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis. J. Neuroimmunol. 327 15\u201321. 10.1016/j.jneuroim.2019.01.007", "ArticleIdList": ["10.1016/j.jneuroim.2019.01.007", "30683426"]}, {"Citation": "Doody R., Ferris S., Salloway S., Sun Y., Goldman R., Watkins W., et al. (2009). Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology 72 1555\u20131561. 10.1212/01.wnl.0000344650.95823.03", "ArticleIdList": ["10.1212/01.wnl.0000344650.95823.03", "19176895"]}, {"Citation": "Doolaanea A. A., Mansor N. I., Mohd Nor N. H., Mohamed F. J. J. O. M. (2016). Co-encapsulation of Nigella sativa oil and plasmid DNA for enhanced gene therapy of Alzheimer\u2019s disease. J. Microencapsul. 33 114\u2013126. 10.3109/02652048.2015.1134689", "ArticleIdList": ["10.3109/02652048.2015.1134689", "26982435"]}, {"Citation": "Duda J. E., Giasson B. I., Gur T. L., Montine T. J., Robertson D., Biaggioni I., et al. (2000). Immunohistochemical and biochemical studies demonstrate a distinct profile of \u03b1-synuclein permutations in multiple system atrophy. J. Neuropathol. Exp. Neurol. 59 830\u2013841. 10.1093/jnen/59.9.830", "ArticleIdList": ["10.1093/jnen/59.9.830", "11005264"]}, {"Citation": "Dur\u00e3es F., Pinto M., Sousa E. (2018). Old Drugs as New Treatments for Neurodegenerative Diseases. Pharmaceuticals 11:44. 10.3390/ph11020044", "ArticleIdList": ["10.3390/ph11020044", "PMC6027455", "29751602"]}, {"Citation": "Dwivedi N., Shah J., Mishra V., Tambuwala M., Kesharwani P. (2019). Nanoneuromedicine for management of neurodegenerative disorder. J. Drug Deliv. Sci. Technol. 49 477\u2013490. 10.1016/j.jddst.2018.12.021", "ArticleIdList": ["10.1016/j.jddst.2018.12.021"]}, {"Citation": "Elnaggar Y. S., Etman S. M., Abdelmonsif D. A., Abdallah O. Y. (2015b). Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer\u2019s disease: pharmaceutical, biological, and toxicological studies. Int. J. Nanomed. 10:5459. 10.2147/ijn.s87336", "ArticleIdList": ["10.2147/ijn.s87336", "PMC4556290", "26346130"]}, {"Citation": "Elnaggar Y. S., Etman S. M., Abdelmonsif D. A., Abdallah O. Y. (2015a). Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer\u2019s disease: optimization, biological efficacy, and potential toxicity. J. Pharm. Sci. 104 3544\u20133556. 10.1002/jps.24557", "ArticleIdList": ["10.1002/jps.24557", "26147711"]}, {"Citation": "Esteves M., Crist\u00f3v\u00e3o A. C., Saraiva T., Rocha S. M., Baltazar G., Ferreira L., et al. (2015). Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson\u2019s disease. Front. Aging Neurosci. 7:20. 10.3389/fnagi.2015.00020", "ArticleIdList": ["10.3389/fnagi.2015.00020", "PMC4351630", "25798108"]}, {"Citation": "Etman S. M., Elnaggar Y. S., Abdelmonsif D. A., Abdallah O. Y. (2018). Oral brain-targeted microemulsion for enhanced piperine delivery in Alzheimer\u2019s Disease therapy: in vitro appraisal. In Vivo activity, and nanotoxicity. AAPS Pharm. Sci. Tech. 19 3698\u20133711. 10.1208/s12249-018-1180-3", "ArticleIdList": ["10.1208/s12249-018-1180-3", "30238305"]}, {"Citation": "Farzaei M. H., Rahimi R., Nikfar S., Abdollahi M. (2018a). Effect of resveratrol on cognitive and memory performance and mood: A meta-analysis of 225 patients. Pharmacol. Res. 128 338\u2013344. 10.1016/j.phrs.2017.08.009", "ArticleIdList": ["10.1016/j.phrs.2017.08.009", "28844841"]}, {"Citation": "Farzaei M. H., Shahpiri Z., Mehri M. R., Bahramsoltani R., Rezaei M., Raeesdana A., et al. (2018b). Medicinal plants in neurodegenerative diseases: perspective of traditional Persian medicine. Curr. Drug Metab. 19 429\u2013442. 10.2174/1389200219666180305150256", "ArticleIdList": ["10.2174/1389200219666180305150256", "29512453"]}, {"Citation": "Friese M. A., Schattling B., Fugger L. (2014). Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat. Rev. Neurol. 10:225. 10.1038/nrneurol.2014.37", "ArticleIdList": ["10.1038/nrneurol.2014.37", "24638138"]}, {"Citation": "Frozza R. L., Bernardi A., Hoppe J. B., Meneghetti A. B., Battastini A. M., Pohlmann A. R., et al. (2013a). Lipid-core nanocapsules improve the effects of resveratrol against Abeta-induced neuroinflammation. J. Biomed. Nanotechnol. 9 2086\u20132104. 10.1166/jbn.2013.1709", "ArticleIdList": ["10.1166/jbn.2013.1709", "24266263"]}, {"Citation": "Frozza R. L., Bernardi A., Hoppe J. B., Meneghetti A. B., Matte A., Battastini A. M., et al. (2013b). Neuroprotective effects of resveratrol against Abeta administration in rats are improved by lipid-core nanocapsules. Mol. Neurobiol. 47 1066\u20131080. 10.1007/s12035-013-8401-2", "ArticleIdList": ["10.1007/s12035-013-8401-2", "23315270"]}, {"Citation": "F\u00fcnfschilling U., Supplie L. M., Mahad D., Boretius S., Saab A. S., Edgar J., et al. (2012). Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517. 10.1038/nature11007", "ArticleIdList": ["10.1038/nature11007", "PMC3613737", "22622581"]}, {"Citation": "Ganesan P., Ko H.-M., Kim I.-S., Choi D.-K. (2015). Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson\u2019s disease models. Intern. J. Nanomed. 10:6757. 10.2147/ijn.s93918", "ArticleIdList": ["10.2147/ijn.s93918", "PMC4631432", "26604750"]}, {"Citation": "Ghaffari F., Moghaddam A. H., Zare M. J. B., Neuroscience C. (2018). Neuroprotective effect of quercetin nanocrystal in a 6-hydroxydopamine model of parkinson disease: biochemical and behavioral evidence. Basic Clin. Neurosci. 9:317. 10.32598/bcn.9.5.317", "ArticleIdList": ["10.32598/bcn.9.5.317", "PMC6360495", "30719246"]}, {"Citation": "Ghosh A., Sarkar S., Mandal A. K., Das N. J. P. O. (2013). Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One 8:e57735. 10.1371/journal.pone.0057735", "ArticleIdList": ["10.1371/journal.pone.0057735", "PMC3631169", "23620721"]}, {"Citation": "Ghosh S., Sarkar S., Choudhury S. T., Ghosh T., Das N. J. (2017). Triphenyl phosphonium coated nano-quercetin for oral delivery: neuroprotective effects in attenuating age related global moderate cerebral ischemia reperfusion injury in rats. Nanomedicine 13 2439\u20132450. 10.1016/j.nano.2017.08.002", "ArticleIdList": ["10.1016/j.nano.2017.08.002", "28822845"]}, {"Citation": "Goetz C. G. (2000). Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot. Muscle Nerve 23 336\u2013343. 10.1002/(sici)1097-4598(200003)23:3<336::aid-mus4>3.0.co;2-l", "ArticleIdList": ["10.1002/(sici)1097-4598(200003)23:3<336::aid-mus4>3.0.co;2-l", "10679709"]}, {"Citation": "Gomes B. A. Q., Silva J., Bastos O. P., Romeiro C. F. R., Dos Santos S., Monteiro V., et al. (2018). Neuroprotective mechanisms of resveratrol in alzheimer\u2019s disease: role of SIRT1. Oxid. Med. Cell. Longev. 2018:15.", "ArticleIdList": ["PMC6232815", "30510627"]}, {"Citation": "Guo Y. Z., He P., Feng A. M. (2017). Effect of curcumin on expressions of NF-\u03baBp65, TNF-\u03b1 and IL-8 in placental tissue of premature birth of infected mice. Asian Pac. J. Trop. Med. 10 175\u2013178. 10.1016/j.apjtm.2017.01.004", "ArticleIdList": ["10.1016/j.apjtm.2017.01.004", "28237485"]}, {"Citation": "Hajialyani M., Tewari D., Sobarzo-S\u00e1nchez E., Nabavi S. M., Farzaei M. H., Abdollahi M. (2018). Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems. Intern. J. Nanomed. 13:5023. 10.2147/IJN.S174072", "ArticleIdList": ["10.2147/IJN.S174072", "PMC6128268", "30214204"]}, {"Citation": "Hassanzadeh P., Arbabi E., Atyabi F., Dinarvand R. J. L. S. (2018). Ferulic acid-loaded nanostructured lipid carriers: a promising nanoformulation against the ischemic neural injuries. Life Sci. 193 64\u201376. 10.1016/j.lfs.2017.11.046", "ArticleIdList": ["10.1016/j.lfs.2017.11.046", "29196052"]}, {"Citation": "He X., Yang S., Zhang R., Hou L., Xu J., Hu Y., et al. (2019). Smilagenin protects dopaminergic neurons in chronic MPTP/Probenecid-lesioned Parkinson\u2019s disease models. Front. Cell. Neurosci. 13:18. 10.3389/fncel.2019.00018", "ArticleIdList": ["10.3389/fncel.2019.00018", "PMC6371654", "30804756"]}, {"Citation": "Heron M. P. (2018). Deaths: leading causes for 2016. Natl. Vital. Stat. Rep. 67 1\u201377.", "ArticleIdList": ["30248017"]}, {"Citation": "Hodjat M., Rahmani S., Khan F., Niaz K., Navaei-Nigjeh M., Nejad S. M., et al. (2017). Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view. Archiv. Toxicol. 91 2577\u20132597. 10.1007/s00204-017-1979-9", "ArticleIdList": ["10.1007/s00204-017-1979-9", "28516248"]}, {"Citation": "Hoppe J. B., Coradini K., Frozza R. L., Oliveira C. M., Meneghetti A. B., Bernardi A., et al. (2013). Free and nanoencapsulated curcumin suppress \u03b2-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3\u03b2 signaling pathway. Neurobiol. Learn. Mem. 106 134\u2013144. 10.1016/j.nlm.2013.08.001", "ArticleIdList": ["10.1016/j.nlm.2013.08.001", "23954730"]}, {"Citation": "Hu S., Maiti P., Ma Q., Zuo X., Jones M. R., Cole G. M., et al. (2015). Clinical development of curcumin in neurodegenerative disease. Expert. Rev. Neurother. 15 629\u2013637. 10.1586/14737175.2015.1044981", "ArticleIdList": ["10.1586/14737175.2015.1044981", "PMC6800094", "26035622"]}, {"Citation": "Huo X., Zhang Y., Jin X., Li Y., Zhang L. (2019). A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer\u2019s disease. J. Photochem. Photobiol. B Biol. 190 98\u2013102. 10.1016/j.jphotobiol.2018.11.008", "ArticleIdList": ["10.1016/j.jphotobiol.2018.11.008", "30504054"]}, {"Citation": "Hussain G., Rasul A., Anwar H., Aziz N., Razzaq A., Wei W., et al. (2018). Role of plant derived alkaloids and their mechanism in neurodegenerative disorders. Intern. J. Biol. Sci. 14 341\u2013357. 10.7150/ijbs.23247", "ArticleIdList": ["10.7150/ijbs.23247", "PMC5859479", "29559851"]}, {"Citation": "Ismail N., Ismail M., Azmi N. H., Bakar M. F. A., Yida Z., Abdullah M. A., et al. (2017a). Thymoquinone-rich fraction nanoemulsion (TQRFNE) decreases A\u03b240 and A\u03b242 levels by modulating APP processing, up-regulating IDE and LRP1, and down-regulating BACE1 and RAGE in response to high fat/cholesterol diet-induced rats. Biomed. Pharmacothe. 95 780\u2013788. 10.1016/j.biopha.2017.08.074", "ArticleIdList": ["10.1016/j.biopha.2017.08.074", "28892789"]}, {"Citation": "Ismail N., Ismail M., Azmi N. H., Bakar M. F. A., Yida Z., Stanslas J., et al. (2017b). Beneficial effects of TQRF and TQ nano-and conventional emulsions on memory deficit, lipid peroxidation, total antioxidant status, antioxidants genes expression and soluble A\u03b2 levels in high fat-cholesterol diet-induced rats. Chem. Biol. Interact 275 61\u201373. 10.1016/j.cbi.2017.07.014", "ArticleIdList": ["10.1016/j.cbi.2017.07.014", "28734741"]}, {"Citation": "Jain S., Ancheria R. K., Shrivastava S., Soni S. L., Sharma M. (2019). An overview of nanogel\u2013novel drug delivery system. Asian J. Pharm. Res. Dev. 7 47\u201355. 10.22270/ajprd.v7i2.482", "ArticleIdList": ["10.22270/ajprd.v7i2.482"]}, {"Citation": "Jan A. T., Malik M. A., Rahman S., Yeo H. R., Lee E. J., Abdullah T. S., et al. (2017). Perspective insights of exosomes in neurodegenerative diseases: a critical appraisal. Front. Aging Neurosci. 9:317. 10.3389/fnagi.2017.00317", "ArticleIdList": ["10.3389/fnagi.2017.00317", "PMC5626860", "29033828"]}, {"Citation": "Jayamani J., Shanmugam G. (2014). Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation. Eur. J. Med. Chem. 85 352\u2013358. 10.1016/j.ejmech.2014.07.111", "ArticleIdList": ["10.1016/j.ejmech.2014.07.111", "25105923"]}, {"Citation": "Jiang B., Shen R. F., Bi J., Tian X. S., Hinchliffe T., Xia Y. (2015). Catalpol: a potential therapeutic for neurodegenerative diseases. Curr. Med. Chem. 22 1278\u20131291. 10.2174/0929867322666150114151720", "ArticleIdList": ["10.2174/0929867322666150114151720", "25620103"]}, {"Citation": "Jiang W., Li S., Li X. (2015). Therapeutic potential of berberine against neurodegenerative diseases. Sci. China Life Sci. 58 564\u2013569. 10.1007/s11427-015-4829-0", "ArticleIdList": ["10.1007/s11427-015-4829-0", "PMC5823536", "25749423"]}, {"Citation": "Jin Y., Wen J., Garg S., Liu D., Zhou Y., Teng L., et al. (2013). Development of a novel niosomal system for oral delivery of Ginkgo biloba extract. Int. J. Nanomed. 8:421. 10.2147/IJN.S37984", "ArticleIdList": ["10.2147/IJN.S37984", "PMC3559077", "23378764"]}, {"Citation": "Jose S., Sowmya S., Cinu T., Aleykutty N., Thomas S., Souto E. (2014). Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. Eur. J. Pharm. Sci. 63 29\u201335. 10.1016/j.ejps.2014.06.024", "ArticleIdList": ["10.1016/j.ejps.2014.06.024", "25010261"]}, {"Citation": "Kakkar V., Kaur I. P. (2011). Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem. Toxicol. 49 2906\u20132913. 10.1016/j.fct.2011.08.006", "ArticleIdList": ["10.1016/j.fct.2011.08.006", "21889563"]}, {"Citation": "Kay C., Fisher E., Hayden M. (2014). \u201cHuntington\u2019s Disease chapter 7,\u201d in Handbook of Clinical Neurology, eds Bates G. P., Tabrizi S. J., Jones L. (Oxford: Oxford University Press; )."}, {"Citation": "Khazdair M. R. (2015). The protective effects of nigella sativa and its constituents on induced neurotoxicity. J. Toxicol. 2015:841823. 10.1155/2015/841823", "ArticleIdList": ["10.1155/2015/841823", "PMC4641935", "26604923"]}, {"Citation": "Kheradmand E., Hajizadeh Moghaddam A., Zare M. (2018). Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer\u2019s disease. Biomed. Pharmacother. 97 1096\u20131101. 10.1016/j.biopha.2017.11.047", "ArticleIdList": ["10.1016/j.biopha.2017.11.047", "29136946"]}, {"Citation": "Kim J., Lee H. J., Lee K. W. (2010). Naturally occurring phytochemicals for the prevention of Alzheimer\u2019s disease. J. Neurochem. 112 1415\u20131430. 10.1111/j.1471-4159.2009.06562.x", "ArticleIdList": ["10.1111/j.1471-4159.2009.06562.x", "20050972"]}, {"Citation": "Kim M. H., Kim S.-H., Yang W. M. (2014). Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer\u2019s disease. Plant. Med. 80 1249\u20131258. 10.1055/s-0034-1383038", "ArticleIdList": ["10.1055/s-0034-1383038", "25210998"]}, {"Citation": "Kim M. J., Rehman S. U., Amin F. U., Kim M. O. (2017). Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against A\u03b21-42-induced neuroinflammation and neurodegeneration via the NF-KB/JNK/GSK3\u03b2 signaling pathway. Nanomedicine 13 2533\u20132544. 10.1016/j.nano.2017.06.022", "ArticleIdList": ["10.1016/j.nano.2017.06.022", "28736294"]}, {"Citation": "Kori M., Ayd\u0131n B., Unal S., Arga K. Y., Kazan D. (2016). Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis. Omics 20 645\u2013661. 10.1089/omi.2016.0106", "ArticleIdList": ["10.1089/omi.2016.0106", "27828769"]}, {"Citation": "Kumar P., Sharma G., Kumar R., Singh B., Malik R., Katare O. P., et al. (2016). Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: biochemical, pharmacokinetic and biodistribution evidences. Int. J. Pharm. 515 307\u2013314. 10.1016/j.ijpharm.2016.10.024", "ArticleIdList": ["10.1016/j.ijpharm.2016.10.024", "27756627"]}, {"Citation": "Kundu P., Das M., Tripathy K., Sahoo S. K. (2016). Delivery of dual drug loaded lipid based nanoparticles across the blood\u2013brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson\u2019s disease. ACS Chem. Neurosci. 7 1658\u20131670. 10.1021/acschemneuro.6b00207", "ArticleIdList": ["10.1021/acschemneuro.6b00207", "27642670"]}, {"Citation": "Kuo Y. C., Chen I. Y., Rajesh R. J. (2018). Use of functionalized liposomes loaded with antioxidants to permeate the blood\u2013brain barrier and inhibit \u03b2-amyloid-induced neurodegeneration in the brain. J. Taiwan Instit. Chem. Eng. 87 1\u201314. 10.1016/j.jtice.2018.03.001", "ArticleIdList": ["10.1016/j.jtice.2018.03.001"]}, {"Citation": "Kutzelnigg A., Lassmann H. (2014). Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb. Clin. Neurol. 122 15\u201358. 10.1016/B978-0-444-52001-2.00002-9", "ArticleIdList": ["10.1016/B978-0-444-52001-2.00002-9", "24507512"]}, {"Citation": "K\u0131ralan M., G\u00f6l\u00fckc\u00fc M., Tokg\u00f6z H. J. (2009). Oil and conjugated linolenic acid contents of seeds from important pomegranate cultivars (Punica granatum L.) grown in Turkey. J. Am. Oil Chem. Soc. 86 985\u2013990. 10.1007/s11746-009-1436-x", "ArticleIdList": ["10.1007/s11746-009-1436-x"]}, {"Citation": "Lagoa R., Lopez-Sanchez C., Samhan-Arias A., Ganan C., Garcia-Martinez V., Guti\u00e9rrez-Merino C. (2009). \u201cNeuroprotective effect of kaempferol in the 3-nitropropionic acid model of Huntington\u2019s disease,\u201d in Proceedings of the Europe Meeting 2009 of the Society-for-Free-Radicals-Research, Berlin."}, {"Citation": "Lee Y., Morrison B. M., Li Y., Lengacher S., Farah M. H., Hoffman P. N., et al. (2012). Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443. 10.1038/nature11314", "ArticleIdList": ["10.1038/nature11314", "PMC3408792", "22801498"]}, {"Citation": "Li F., Harmer P., Fitzgerald K., Eckstrom E., Stock R., Galver J., et al. (2012). Tai chi and postural stability in patients with Parkinson\u2019s disease. N. Engl. J. Med. 366 511\u2013519. 10.1056/NEJMoa1107911", "ArticleIdList": ["10.1056/NEJMoa1107911", "PMC3285459", "22316445"]}, {"Citation": "Li J., Zhou L., Ye D., Huang S., Shao K., Huang R., et al. (2011). Choline-derivate-modified nanoparticles for brain-targeting gene delivery. Adv. Mater. 23 4516\u20134520. 10.1002/adma.201101899", "ArticleIdList": ["10.1002/adma.201101899", "21898606"]}, {"Citation": "Lloret S. P., Rey M. V., Rascol O. (2013). Ayurveda medicine for the treatment of Parkinson\u2019s Disease. Int. Integrat. Med. 1 1\u20136."}, {"Citation": "Logroscino G., Traynor B., Hardiman O., Couratier P., Mitchell J., Swingler R., et al. (2008). Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J. Neurol. Neurosurg. Psychiatr. 79 6\u201311. 10.1136/jnnp.2006.104828", "ArticleIdList": ["10.1136/jnnp.2006.104828", "18079297"]}, {"Citation": "Logroscino G., Traynor B. J., Hardiman O., Chi\u00f2 A., Mitchell D., Swingler R. J., et al. (2010). Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatr. 81 385\u2013390.", "ArticleIdList": ["PMC2850819", "19710046"]}, {"Citation": "Lohan S., Raza K., Mehta S. K., Bhatti G. K., Saini S., Singh B. (2017). Anti-Alzheimer\u2019s potential of berberine using surface decorated multi-walled carbon nanotubes: a preclinical evidence. Intern. J. Pharm. 530 263\u2013278. 10.1016/j.ijpharm.2017.07.080", "ArticleIdList": ["10.1016/j.ijpharm.2017.07.080", "28774853"]}, {"Citation": "Lu X., Ji C., Xu H., Li X., Ding H., Ye M., et al. (2009). Resveratrol-loaded polymeric micelles protect cells from A\u03b2-induced oxidative stress. Brain Res. 375 89\u201396. 10.1016/j.ijpharm.2009.03.021", "ArticleIdList": ["10.1016/j.ijpharm.2009.03.021", "19481694"]}, {"Citation": "Luo Y. (2001). Ginkgo biloba neuroprotection: therapeutic implications in Alzheimer\u2019s disease. J. Alzheimers Dis. 3 401\u2013407. 10.3233/jad-2001-3407", "ArticleIdList": ["10.3233/jad-2001-3407", "12214044"]}, {"Citation": "Maravajhala V., Papishetty S., Bandlapalli S. (2012). Nanotechnology in development of drug delivery system. Intern. J. Pharm. Sci. Res. 3:84."}, {"Citation": "Marin L. D., Sanchez-Borzone M., Garcia D. A. (2011). Comparative antioxidant properties of some GABAergic phenols and related compounds, determined for homogeneous and membrane systems. Med. Chem. 7 317\u2013324. 10.2174/157340611796150969", "ArticleIdList": ["10.2174/157340611796150969", "21568883"]}, {"Citation": "Mathew A., Fukuda T., Nagaoka Y., Hasumura T., Morimoto H., Yoshida Y., et al. (2012). Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS One 7:e32616. 10.1371/journal.pone.0032616", "ArticleIdList": ["10.1371/journal.pone.0032616", "PMC3293842", "22403681"]}, {"Citation": "Maurer K., Ihl R., Dierks T., Fr\u00f6lich L. J. (1997). Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J. Psychiatr. Res. 31 645\u2013655. 10.1016/s0022-3956(97)00022-8", "ArticleIdList": ["10.1016/s0022-3956(97)00022-8", "9447569"]}, {"Citation": "Mckeith I. G., Galasko D., Kosaka K., Perry E., Dickson D. W., Hansen L., et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 1113\u20131124.", "ArticleIdList": ["8909416"]}, {"Citation": "Meng F., Asghar S., Gao S., Su Z., Song J., Huo M., et al. (2015). A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer\u2019s disease. Coll. Surf. B Biointerf. 134 88\u201397. 10.1016/j.colsurfb.2015.06.025", "ArticleIdList": ["10.1016/j.colsurfb.2015.06.025", "26162977"]}, {"Citation": "Meng Q., Wang A., Hua H., Jiang Y., Wang Y., Mu H., et al. (2018). Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease. Intern. Nanomed. 13:705. 10.2147/ijn.s151474", "ArticleIdList": ["10.2147/ijn.s151474", "PMC5798568", "29440896"]}, {"Citation": "Mhillaj E., Catino S., Miceli F. M., Santangelo R., Trabace L., Cuomo V., et al. (2018). Ferulic acid improves cognitive skills through the activation of the heme oxygenase system in the rat. Mol. Neurobiol. 55 905\u2013916. 10.1007/s12035-017-0381-1", "ArticleIdList": ["10.1007/s12035-017-0381-1", "28083818"]}, {"Citation": "Min J. B., Kim E. S., Lee J.-S., Lee H. G. J. F. S. (2018). Preparation, characterization, and cellular uptake of resveratrol-loaded trimethyl chitosan nanoparticles. Food Sci. Biotechnol. 27 1\u201310. 10.1007/s10068-017-0272-2", "ArticleIdList": ["10.1007/s10068-017-0272-2", "PMC6049628", "30263768"]}, {"Citation": "Mizrahi M., Friedman-Levi Y., Larush L., Frid K., Binyamin O., Dori D., et al. (2014). Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD. Nanomedicine 10 1353\u20131363. 10.1016/j.nano.2014.03.015", "ArticleIdList": ["10.1016/j.nano.2014.03.015", "24704590"]}, {"Citation": "Mizuno Y. (2014). Recent research progress in and future perspective on treatment of Parkinson\u2019s disease. Integr. Med. Intern. 1 67\u201379. 10.1159/000365571", "ArticleIdList": ["10.1159/000365571"]}, {"Citation": "Modi G., Pillay V., Choonara Y. E. (2010). Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann. N. Y. Acad. Sci. 1184 154\u2013172. 10.1111/j.1749-6632.2009.05108.x", "ArticleIdList": ["10.1111/j.1749-6632.2009.05108.x", "20146696"]}, {"Citation": "Modi G., Pillay V., Choonara Y. E., Ndesendo V. M., Du Toit L. C., Naidoo D. (2009). Nanotechnological applications for the treatment of neurodegenerative disorders. Prog. Neurobiol. 88 272\u2013285. 10.1016/j.pneurobio.2009.05.002", "ArticleIdList": ["10.1016/j.pneurobio.2009.05.002", "19486920"]}, {"Citation": "Mohajeri M., Sadeghizadeh M., Najafi F., Javan M. J. N. (2015). Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Neuropharmacology 99 156\u2013167. 10.1016/j.neuropharm.2015.07.013", "ArticleIdList": ["10.1016/j.neuropharm.2015.07.013", "26211978"]}, {"Citation": "Mohammad-Beigi H., Morshedi D., Shojaosadati S. A., Pedersen J. N., Marvian A. T., Aliakbari F., et al. (2016). Gallic acid loaded onto polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA-GA NPs) stabilizes \u03b1-synuclein in the unfolded conformation and inhibits aggregation. RSC Adv. 6 85312\u201385323. 10.1039/c6ra08502d", "ArticleIdList": ["10.1039/c6ra08502d"]}, {"Citation": "Momtaz S., Hassani S., Khan F., Ziaee M., Abdollahi M. (2018). Cinnamon, a promising prospect towards Alzheimer\u2019s disease. Pharmacol. Res. 130 241\u2013258. 10.1016/j.phrs.2017.12.011", "ArticleIdList": ["10.1016/j.phrs.2017.12.011", "29258915"]}, {"Citation": "Morgan S., Orrell R. W. (2016). Pathogenesis of amyotrophic lateral sclerosis. Br. Med. Bull. 119 87\u201398. 10.1093/bmb/ldw026", "ArticleIdList": ["10.1093/bmb/ldw026", "27450455"]}, {"Citation": "Morozova N., Weisskopf M. G., Mccullough M. L., Munger K. L., Calle E. E., Thun M. J., et al. (2008). Diet and amyotrophic lateral sclerosis. Epidemiology 19 324\u2013337. 10.1097/EDE.0b013e3181632c5d", "ArticleIdList": ["10.1097/EDE.0b013e3181632c5d", "18300717"]}, {"Citation": "Mourtas S., Canovi M., Zona C., Aurilia D., Niarakis A., La Ferla B., et al. (2011). Curcumin-decorated nanoliposomes with very high affinity for amyloid-\u03b21-42 peptide. Biomaterials 32 1635\u20131645. 10.1016/j.biomaterials.2010.10.027", "ArticleIdList": ["10.1016/j.biomaterials.2010.10.027", "21131044"]}, {"Citation": "Mourtas S., Lazar A. N., Markoutsa E., Duyckaerts C., Antimisiaris S. G. (2014). Multifunctional nanoliposomes with curcumin\u2013lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur. J. Med. Chem. 80 175\u2013183. 10.1016/j.ejmech.2014.04.050", "ArticleIdList": ["10.1016/j.ejmech.2014.04.050", "24780594"]}, {"Citation": "Mulik R. S., M\u00f6nkk\u00f6nen J., Juvonen R. O., Mahadik K. R., Paradkar A. R. (2010). ApoE3 mediated Poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mol. Pharm. 7 815\u2013825. 10.1021/mp900306x", "ArticleIdList": ["10.1021/mp900306x", "20230014"]}, {"Citation": "M\u00fcller W. E., Heiser J., Leuner K. J. I. P. (2012). Effects of the standardized Ginkgo biloba extract EGb 761 on neuroplasticity. Int. Psychogeriatr. 24 S21\u2013S24. 10.1017/S1041610212000592", "ArticleIdList": ["10.1017/S1041610212000592", "22784424"]}, {"Citation": "Nabavi S. F., Devi K. P., Malar D. S., Sureda A., Daglia M., Nabavi S. M. (2015). Ferulic acid and Alzheimer\u2019s disease: promises and pitfalls. Mini. Rev. Med. Chem. 15 776\u2013788. 10.2174/1389557515666150522102545", "ArticleIdList": ["10.2174/1389557515666150522102545", "26002710"]}, {"Citation": "Naeimi R., Safarpour F., Hashemian M., Tashakorian H., Ahmadian S. R., Ashrafpour M., et al. (2018). Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lyolecithin-induced focal demyelination model of rat corpus callosum. Neurosci. Lett. 674 1\u201310. 10.1016/j.neulet.2018.03.018", "ArticleIdList": ["10.1016/j.neulet.2018.03.018", "29530814"]}, {"Citation": "Nagpal K., Singh S., Mishra D. J. D. D. (2013). Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamine-induced amnesia. Drug Deliv. 20 112\u2013119. 10.3109/10717544.2013.779330", "ArticleIdList": ["10.3109/10717544.2013.779330", "23651033"]}, {"Citation": "Naoi M., Inaba-Hasegawa K., Shamoto-Nagai M., Maruyama W. (2017). Neurotrophic function of phytochemicals for neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signaling and gene expression. J. Neural Trans. 124 1515\u20131527. 10.1007/s00702-017-1797-5", "ArticleIdList": ["10.1007/s00702-017-1797-5", "29030688"]}, {"Citation": "Naoi M., Shamoto-Nagai M., Maruyama W. (2019). Neuroprotection of multifunctional phytochemicals as novel therapeutic strategy for neurodegenerative disorders: antiapoptotic and antiamyloidogenic activities by modulation of cellular signal pathways. Future Med. 14:FNL9."}, {"Citation": "Nathiya S., Durga M., Devasena T. J. A. (2014). Quercetin, encapsulated quercetin and its application\u2013A review. Intern. J. Pharm. Pharm. Sci. 6 20\u201326."}, {"Citation": "Naz S., Shamoon M., Wang R., Zhang L., Zhou J., Chen J. (2019). Advances in therapeutic implications of inorganic drug delivery nano-platforms for cancer. Intern. J. Mol. Sci 20:965. 10.3390/ijms20040965", "ArticleIdList": ["10.3390/ijms20040965", "PMC6413464", "30813333"]}, {"Citation": "Neves A. R., Queiroz J. F., Reis S. J. J. O. N. (2016). Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. J. Nanobiotechnol. 14:27. 10.1186/s12951-016-0177-x", "ArticleIdList": ["10.1186/s12951-016-0177-x", "PMC4826547", "27061902"]}, {"Citation": "Nisi Zhang F. Y., Liang X., Wu M., Shen Y., Chen M., Xu Y., et al. (2018). Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson\u2019s disease therapy. Theranostics 8 2264\u20132277. 10.7150/thno.23734", "ArticleIdList": ["10.7150/thno.23734", "PMC5928888", "29721078"]}, {"Citation": "Niu X., Chen J., Gao J. (2019). Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: focus on recent advances. Asian J. Pharm. Sci. 14 480\u2013496. 10.1016/j.ajps.2018.09.005", "ArticleIdList": ["10.1016/j.ajps.2018.09.005", "PMC7032222", "32104476"]}, {"Citation": "Ochekpe N. A., Olorunfemi P. O., Ngwuluka N. C. (2009). Nanotechnology and drug delivery part 1: background and applications. Trop. J. Pharm. Res. 8 265\u2013274. 10.2174/1871520619666191028112258", "ArticleIdList": ["10.2174/1871520619666191028112258", "31746307"]}, {"Citation": "Okun M. S. (2014). Deep-brain stimulation\u2013entering the era of human neural-network modulation. N. Engl. J. Med. 371 1369\u20131373. 10.1056/nejmp1408779", "ArticleIdList": ["10.1056/nejmp1408779", "25197963"]}, {"Citation": "Pagliosa L. B., Monteiro S. C., Silva K. B., De Andrade J. P., Dutilh J., Bastida J., et al. (2010). Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity. Phytomedicine 17 698\u2013701. 10.1016/j.phymed.2009.10.003", "ArticleIdList": ["10.1016/j.phymed.2009.10.003", "19969445"]}, {"Citation": "Pan W., Kwak S., Liu Y., Sun Y., Fang Z., Qin B., et al. (2011a). Traditional chinese medicine improves activities of daily living in Parkinson\u2019s disease. Parkinson Dis. 2011:789506.", "ArticleIdList": ["PMC3109418", "21687764"]}, {"Citation": "Pan W., Liu Y., Fang Z., Zhu X., Pan W., Kwak S., et al. (2011b). A compound belonging to traditional Chinese medicine improves nocturnal activity in Parkinson\u2019s disease. Sleep Med. 12:307. 10.1016/j.sleep.2010.07.016", "ArticleIdList": ["10.1016/j.sleep.2010.07.016", "21256807"]}, {"Citation": "Pan W., Wang Q., Kwak S., Song Y., Qin B., Wang M., et al. (2014). Shen-zhi-ling oral liquid improves behavioral and psychological symptoms of dementia in Alzheimer\u2019s disease. Evid. Based Complem. Altern. Med. 2014:6.", "ArticleIdList": ["PMC4052178", "24959193"]}, {"Citation": "Pan W., Zhou H. (2014). Inclusion of integrative medicine in clinical practice. Integr. Med. Intern. 1 1\u20134. 10.1159/000362628", "ArticleIdList": ["10.1159/000362628"]}, {"Citation": "Pandareesh M. D., Mythri R. B., Srinivas Bharath M. M. (2015). Bioavailability of dietary polyphenols: factors contributing to their clinical application in CNS diseases. Neurochem. Intern. 89 198\u2013208. 10.1016/j.neuint.2015.07.003", "ArticleIdList": ["10.1016/j.neuint.2015.07.003", "26163045"]}, {"Citation": "Pangeni R., Sharma S., Mustafa G., Ali J., Baboota S. J. N. (2014). Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson\u2019s disease by reducing oxidative stress. Nanotechnology 25:485102. 10.1088/0957-4484/25/48/485102", "ArticleIdList": ["10.1088/0957-4484/25/48/485102", "25392203"]}, {"Citation": "Patil S. P., Jain P. D., Sancheti J. S., Ghumatkar P. J., Tambe R., Sathaye S. (2014). Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice. Neuropharmacology 86 192\u2013202. 10.1016/j.neuropharm.2014.07.012", "ArticleIdList": ["10.1016/j.neuropharm.2014.07.012", "25087727"]}, {"Citation": "Penke B., Bog\u00e1r F., F\u00fcl\u00f6p L. (2017). \u03b2-Amyloid and the Pathomechanisms of Alzheimer\u2019s disease: a comprehensive view. Molecules 22:1692. 10.3390/molecules22101692", "ArticleIdList": ["10.3390/molecules22101692", "PMC6151811", "28994715"]}, {"Citation": "Phachonpai W., Wattanathorn J., Muchimapura S., Tong-Un T., Preechagoon D. J. (2010). Neuroprotective effect of quercetin encapsulated liposomes: a novel therapeutic strategy against Alzheimer\u2019s disease. Am. J. Appl. Sci. 7 480\u2013485. 10.3844/ajassp.2010.480.485", "ArticleIdList": ["10.3844/ajassp.2010.480.485"]}, {"Citation": "Picone P., Bondi M. L., Picone P., Bondi M. L., Montana G., Bruno A., et al. (2009). Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: improved delivery by solid lipid nanoparticles. Free Radic. Res. 43 1133\u20131145. 10.1080/10715760903214454", "ArticleIdList": ["10.1080/10715760903214454", "19863373"]}, {"Citation": "Polman C. H., Reingold S. C., Banwell B., Clanet M., Cohen J. A., Filippi M., et al. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69 292\u2013302. 10.1002/ana.22366", "ArticleIdList": ["10.1002/ana.22366", "PMC3084507", "21387374"]}, {"Citation": "Poovaiah N., Davoudi Z., Peng H., Schlichtmann B., Mallapragada S., Narasimhan B., et al. (2018). Treatment of neurodegenerative disorders through the blood\u2013brain barrier using nanocarriers. Nanoscale 10 16962\u201316983. 10.1039/c8nr04073g", "ArticleIdList": ["10.1039/c8nr04073g", "30182106"]}, {"Citation": "Prema A., Janakiraman U., Manivasagam T., Thenmozhi A. J. (2015). Neuroprotective effect of lycopene against MPTP induced experimental Parkinson\u2019s disease in mice. Neurosci. Lett. 599 12\u201319. 10.1016/j.neulet.2015.05.024", "ArticleIdList": ["10.1016/j.neulet.2015.05.024", "25980996"]}, {"Citation": "Price J. L., Davis P., Morris J., White D. (1991). The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer\u2019s disease. Neurobiol. Aging 12 295\u2013312. 10.1016/0197-4580(91)90006-6", "ArticleIdList": ["10.1016/0197-4580(91)90006-6", "1961359"]}, {"Citation": "Przedborski S., Vila M., Jackson-Lewis V. (2003). Neurodegeneration: what is it and where are we? J. Clin. Invest. 111 3\u201310.", "ArticleIdList": ["PMC151843", "12511579"]}, {"Citation": "Qian Y., Guan T., Huang M., Cao L., Li Y., Cheng H., et al. (2012). Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria-dependent apoptosis pathways and reactive oxygen induced-NF-kappaB activation in a cerebral ischemia mouse model. Neurochem. Int. 60 759\u2013767. 10.1016/j.neuint.2012.03.011", "ArticleIdList": ["10.1016/j.neuint.2012.03.011", "22490611"]}, {"Citation": "Quik M., Perez X. A., Bordia T. (2012). Nicotine as a potential neuroprotective agent for Parkinson\u2019s disease. Mov. Disord. 27 947\u2013957. 10.1002/mds.25028", "ArticleIdList": ["10.1002/mds.25028", "PMC3685410", "22693036"]}, {"Citation": "Ramanathan S., Archunan G., Sivakumar M., Tamil Selvan S., Fred A. L., Kumar S., et al. (2018). Theranostic applications of nanoparticles in neurodegenerative disorders. Intern. J. Nanomed. 13 5561\u20135576. 10.2147/IJN.S149022", "ArticleIdList": ["10.2147/IJN.S149022", "PMC6154717", "30271147"]}, {"Citation": "Ratheesh G., Tian L., Venugopal J. R., Ezhilarasu H., Sadiq A., Fan T.-P., et al. (2017). Role of medicinal plants in neurodegenerative diseases. Biomanufactur. Rev. 2:2."}, {"Citation": "Re F., Gregori M., Masserini M. (2012). Nanotechnology for neurodegenerative disorders. Maturitas 73 45\u201351. 10.1016/j.maturitas.2011.12.015", "ArticleIdList": ["10.1016/j.maturitas.2011.12.015", "22261367"]}, {"Citation": "Rehman M. U., Wali A. F., Ahmad A., Shakeel S., Rasool S., Ali R., et al. (2019). Neuroprotective strategies for neurological disorders by natural products: an update. Curr. Neuropharmacol. 17 247\u2013267. 10.2174/1570159X16666180911124605", "ArticleIdList": ["10.2174/1570159X16666180911124605", "PMC6425075", "30207234"]}, {"Citation": "Rocca W. A. (2018). The burden of Parkinson\u2019s disease: a worldwide perspective. Lancet Neurol. 17 928\u2013929. 10.1016/s1474-4422(18)30355-7", "ArticleIdList": ["10.1016/s1474-4422(18)30355-7", "30287052"]}, {"Citation": "Rogan S., Lippa C. F. (2002). Alzheimer\u2019s disease and other dementias: a review. Am. J. Alzheimer Dis. Other Dement. 17 11\u201317.", "ArticleIdList": ["11831415"]}, {"Citation": "Roney C., Kulkarni P., Arora V., Antich P., Bonte F., Wu A., et al. (2005). Targeted nanoparticles for drug delivery through the blood\u2013brain barrier for Alzheimer\u2019s disease. J. Control. Release 108 193\u2013214.", "ArticleIdList": ["16246446"]}, {"Citation": "Ross C. A., Aylward E. H., Wild E. J., Langbehn D. R., Long J. D., Warner J. H., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 10:204. 10.1038/nrneurol.2014.24", "ArticleIdList": ["10.1038/nrneurol.2014.24", "24614516"]}, {"Citation": "Samudre S., Tekade A., Thorve K., Jamodkar A., Parashar G., Chaudhari N. J. D. D. L. (2015). Xanthan gum coated mucoadhesive liposomes for efficient nose to brain delivery of curcumin. Drug Deliv. Lett. 5 201\u2013207. 10.2174/2210303106666160120215857", "ArticleIdList": ["10.2174/2210303106666160120215857"]}, {"Citation": "Sancini G., Gregori M., Salvati E., Cambianica I., Re F., Ornaghi F., et al. (2013). Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-\u03b2 peptide. Science 4 1\u20138."}, {"Citation": "Sandhir R., Yadav A., Mehrotra A., Sunkaria A., Singh A., Sharma S. J. N. M. (2014). Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington\u2019s disease. Neuromol. Med. 16 106\u2013118. 10.1007/s12017-013-8261-y", "ArticleIdList": ["10.1007/s12017-013-8261-y", "24008671"]}, {"Citation": "Sarko D. K., Mckinney C. E. (2017). Exosomes: origins and therapeutic potential for neurodegenerative disease. Front. Neurosci. 11:82. 10.3389/fnins.2017.00082", "ArticleIdList": ["10.3389/fnins.2017.00082", "PMC5326777", "28289371"]}, {"Citation": "Scalfari A., Neuhaus A., Daumer M., Muraro P. A., Ebers G. C. (2014). Onset of secondary progressive phase and long-term evolution of multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 85 67\u201375. 10.1136/jnnp-2012-304333", "ArticleIdList": ["10.1136/jnnp-2012-304333", "23486991"]}, {"Citation": "Schrag A., Horsfall L., Walters K., Noyce A., Petersen I. (2015). Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study. Lancet Neurol. 14 57\u201364. 10.1016/s1474-4422(14)70287-x", "ArticleIdList": ["10.1016/s1474-4422(14)70287-x", "25435387"]}, {"Citation": "Shao-Ling W., Ying L., Ying W., Yan-Feng C., Li-Xin N., Song-Tao L., et al. (2009). Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed. Environ. Sci. 22 32\u201339. 10.1016/S0895-3988(09)60019-2", "ArticleIdList": ["10.1016/S0895-3988(09)60019-2", "19462685"]}, {"Citation": "Shea T. B., Ortiz D., Nicolosi R. J., Kumar R., Watterson A. C. (2005). Nanosphere-mediated delivery of vitamin E increases its efficacy against oxidative stress resulting from exposure to amyloid beta. J. Alzheimer Dis. 7 297\u2013301. 10.3233/jad-2005-7405", "ArticleIdList": ["10.3233/jad-2005-7405", "16131731"]}, {"Citation": "Shi C., Liu J., Wu F., Yew D. T. (2010). Ginkgo biloba extract in Alzheimer\u2019s disease: from action mechanisms to medical practice. Intern. J. Mol. Sci. 11 107\u2013123. 10.3390/ijms11010107", "ArticleIdList": ["10.3390/ijms11010107", "PMC2820992", "20162004"]}, {"Citation": "Shinji S., Yasukazu T., Hatsue W., Kazuo K., Machiko I., Naoki M. J. (2011). Analysis of brain cell activation by nanosized particles of Ginkgo biloba extract. Acad. J. 3 28\u201333."}, {"Citation": "Singh N. A., Mandal A. K. A., Khan Z. A. (2016). Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Nutr. J. 15 60\u201360.", "ArticleIdList": ["PMC4897892", "27268025"]}, {"Citation": "Smith A., Giunta B., Bickford P. C., Fountain M., Tan J., Shytle R. D. (2010). Nanolipidic particles improve the bioavailability and \u03b1-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer\u2019s disease. Int. J. Pharm. 389 207\u2013212. 10.1016/j.ijpharm.2010.01.012", "ArticleIdList": ["10.1016/j.ijpharm.2010.01.012", "PMC5831366", "20083179"]}, {"Citation": "Stoffels J. M., De Jonge J. C., Stancic M., Nomden A., Van Strien M. E., Ma D., et al. (2013). Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Brain 136 116\u2013131. 10.1093/brain/aws313", "ArticleIdList": ["10.1093/brain/aws313", "23365094"]}, {"Citation": "Strathearn K. E., Yousef G. G., Grace M. H., Roy S. L., Tambe M. A., Ferruzzi M. G., et al. (2014). Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson\u00d7s disease. Brain Res. 1555 60\u201377. 10.1016/j.brainres.2014.01.047", "ArticleIdList": ["10.1016/j.brainres.2014.01.047", "PMC4024464", "24502982"]}, {"Citation": "Sun D., Li N., Zhang W., Zhao Z., Mou Z., Huang D., et al. (2016). Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer\u2019s disease. Coll. Surf. B Biointerf. 148 116\u2013129. 10.1016/j.colsurfb.2016.08.052", "ArticleIdList": ["10.1016/j.colsurfb.2016.08.052", "27591943"]}, {"Citation": "Sun J., Wei C., Liu Y., Xie W., Xu M., Zhou H., et al. (2019). Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer\u2019s disease. Biomaterials 197 417\u2013431. 10.1016/j.biomaterials.2018.12.027", "ArticleIdList": ["10.1016/j.biomaterials.2018.12.027", "30638753"]}, {"Citation": "Szwajgier D., Borowiec K., Pustelniak K. (2017). The neuroprotective effects of phenolic acids: molecular mechanism of action. Nutrients 9:477. 10.3390/nu9050477", "ArticleIdList": ["10.3390/nu9050477", "PMC5452207", "28489058"]}, {"Citation": "Taghipour Y. D., Hajialyani M., Naseri R., Hesari M., Mohammadi P., Stefanucci A., et al. (2019). Nanoformulations of natural products for management of metabolic syndrome. Intern. J. Nanomed. 14:5303. 10.2147/IJN.S213831", "ArticleIdList": ["10.2147/IJN.S213831", "PMC6642644", "31406461"]}, {"Citation": "Taylor M., Moore S., Mourtas S., Niarakis A., Re F., Zona C., et al. (2011). Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer\u2019s A\u03b2 peptide. Nanomed. Nanotechnol. Biol. Med. 7 541\u2013550. 10.1016/j.nano.2011.06.015", "ArticleIdList": ["10.1016/j.nano.2011.06.015", "21722618"]}, {"Citation": "Tellone E., Galtieri A., Russo A., Ficarra S. (2017). Protective effects of the caffeine against neurodegenerative diseases. Curr. Med. Chem. 26 5137\u20135151. 10.2174/0929867324666171009104040", "ArticleIdList": ["10.2174/0929867324666171009104040", "28990513"]}, {"Citation": "Tiwari S. K., Agarwal S., Seth B., Yadav A., Nair S., Bhatnagar P., et al. (2013). Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical Wnt/\u03b2-catenin pathway. ACS Nano 8 76\u2013103. 10.1021/nn405077y", "ArticleIdList": ["10.1021/nn405077y", "24467380"]}, {"Citation": "Tizabi Y., Hurley L. L., Qualls Z., Akinfiresoye L. (2014). Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression. Molecules 19 20864\u201320879. 10.3390/molecules191220864", "ArticleIdList": ["10.3390/molecules191220864", "PMC6270664", "25514226"]}, {"Citation": "Tonda-Turo C., Origlia N., Mattu C., Accorroni A., Chiono V. (2018). Current limitations in the Treatment of Parkinson\u2019s and Alzheimer\u2019s diseases: state-of-the-art and future perspective of polymeric carriers. Curr. Med. Chem. 25 5755\u20135771. 10.2174/0929867325666180221125759", "ArticleIdList": ["10.2174/0929867325666180221125759", "29473493"]}, {"Citation": "Trombino S., Cassano R., Ferrarelli T., Barone E., Picci N., Mancuso C. J. C., et al. (2013). Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Coll. Surf. B Biointerf. 109 273\u2013279. 10.1016/j.colsurfb.2013.04.005", "ArticleIdList": ["10.1016/j.colsurfb.2013.04.005", "23668982"]}, {"Citation": "Vedagiri A., Thangarajan S. (2016). Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid \u03b225\u201335 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer\u2019s disease. Neuropeptides 58 111\u2013125. 10.1016/j.npep.2016.03.002", "ArticleIdList": ["10.1016/j.npep.2016.03.002", "27021394"]}, {"Citation": "Vital M. J. S., Carneiro A. L. B., e Silva L. F. R., Amorim R. C. N., Camargo M. R. M., Pohlit A. M. (2015). Chemical Composition, Ethnopharmacology and Biological Activity of Geissospermum Allem\u00e3o Species (Apocynaceae Juss.), Vol. 8 Brazil: Funda\u00e7\u00e3o Oswaldo Cruz. Farmanguinhos. N\u00facleo de Gest\u00e3o em Biodiversidade e Sa\u00fade."}, {"Citation": "Vroegrijk I. O., Van Diepen J. A., Van Den Berg S., Westbroek I., Keizer H., Gambelli L., et al. (2011). Pomegranate seed oil, a rich source of punicic acid, prevents diet-induced obesity and insulin resistance in mice. Food Chem. Toxicol. 49 1426\u20131430. 10.1016/j.fct.2011.03.037", "ArticleIdList": ["10.1016/j.fct.2011.03.037", "21440024"]}, {"Citation": "Wang B., Su C. J., Liu T. T., Zhou Y., Feng Y., Huang Y., et al. (2018). The neuroprotection of low-dose morphine in cellular and animal models of Parkinson\u2019s disease through ameliorating endoplasmic reticulum (ER) stress and activating autophagy. Front. Mol. Neurosci. 11:120. 10.3389/fnmol.2018.00120", "ArticleIdList": ["10.3389/fnmol.2018.00120", "PMC5920031", "29731707"]}, {"Citation": "Wang X., Li G., Zhang P., Li W., He X. J. (2019). Surface engineering of resveratrol to improve neuro-protection and functional recovery after spinal cord injury in rat. J. Drug Deliv. Sci. Technol. 49 89\u201396. 10.1016/j.jddst.2018.10.016", "ArticleIdList": ["10.1016/j.jddst.2018.10.016"]}, {"Citation": "Wang Z. H., Wang Z. Y., Sun C. S., Wang C. Y., Jiang T. Y., Wang S. L. J. B. (2010). Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials 31 908\u2013915. 10.1016/j.biomaterials.2009.09.104", "ArticleIdList": ["10.1016/j.biomaterials.2009.09.104", "19853292"]}, {"Citation": "Win-Shwe T. T., Fujimaki H. (2011). Nanoparticles and neurotoxicity. Intern. J. Mol. Sci. 12 6267\u20136280. 10.3390/ijms12096267", "ArticleIdList": ["10.3390/ijms12096267", "PMC3189781", "22016657"]}, {"Citation": "World Health Organization (2006). Neurological Disorders: Public Health Challenges. (Geneva: World Health Organization; )."}, {"Citation": "World Health Organization (2018). The Top 10 Causes Of Death. Geneva: World Health Organization."}, {"Citation": "Xiang C., Zhang Y., Guo W., Liang X. J. (2019). Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication. Acta Pharm. Sin. B 10 239\u2013248. 10.1016/j.apsb.2019.11.003", "ArticleIdList": ["10.1016/j.apsb.2019.11.003", "PMC7016289", "32082970"]}, {"Citation": "Xiao X.-Y., Zhu Y.-X., Bu J.-Y., Li G.-W., Zhou J.-H., Zhou S. P. (2016). Evaluation of neuroprotective effect of thymoquinone nanoformulation in the rodent cerebral ischemia-reperfusion model. Biomed. Res. Intern. 2016:2571060.", "ArticleIdList": ["PMC5048094", "27725936"]}, {"Citation": "Xie J., Shen Z., Anraku Y., Kataoka K., Chen X. (2019). Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224:119491. 10.1016/j.biomaterials.2019.119491", "ArticleIdList": ["10.1016/j.biomaterials.2019.119491", "PMC6915305", "31546096"]}, {"Citation": "Yang X., Zheng T., Hong H., Cai N., Zhou X., Sun C., et al. (2018). Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen\u2013glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model. Front. Med. 12:307. 10.1007/s11684-017-0547-2", "ArticleIdList": ["10.1007/s11684-017-0547-2", "29058254"]}, {"Citation": "Yasuda T., Mochizuki H. (2010). The regulatory role of \u03b1-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson\u2019s disease. Apoptosis 15 1312\u20131321. 10.1007/s10495-010-0486-8", "ArticleIdList": ["10.1007/s10495-010-0486-8", "20221696"]}, {"Citation": "Yin T., Yang L., Liu Y., Zhou X., Sun J., Liu J. (2015). Sialic acid (SA)-modified selenium nanoparticles coated with a high blood\u2013brain barrier permeability peptide-B6 peptide for potential use in Alzheimer\u2019s disease. Acta Biomater. 25 172\u2013183. 10.1016/j.actbio.2015.06.035", "ArticleIdList": ["10.1016/j.actbio.2015.06.035", "26143603"]}, {"Citation": "Yu Y., Hayashi S., Cai X., Fang C., Shi W., Tsutsui H., et al. (2014). Pu-erh tea extract induces the degradation of FET family proteins involved in the pathogenesis of amyotrophic lateral sclerosis. Biomed. Res. Intern. 2014:254680. 10.1155/2014/254680", "ArticleIdList": ["10.1155/2014/254680", "PMC3997874", "24804206"]}, {"Citation": "Yusuf M., Khan M., Khan R. A., Ahmed B. J. (2013). Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model. J. Drug Target. 21 300\u2013311. 10.3109/1061186x.2012.747529", "ArticleIdList": ["10.3109/1061186x.2012.747529", "23231324"]}, {"Citation": "Zarei S., Carr K., Reiley L., Diaz K., Guerra O., Altamirano P. F., et al. (2015). A comprehensive review of amyotrophic lateral sclerosis. Surg. Neurol. Intern. 6:171. 10.4103/2152-7806.169561", "ArticleIdList": ["10.4103/2152-7806.169561", "PMC4653353", "26629397"]}, {"Citation": "Zhang C., Browne A., Child D., Tanzi R. E. (2010). Curcumin decreases amyloid-\u03b2 peptide levels by attenuating the maturation of amyloid-\u03b2 precursor protein. J. Biol. Chem. 285 28472\u201328480. 10.1074/jbc.M110.133520", "ArticleIdList": ["10.1074/jbc.M110.133520", "PMC2937872", "20622013"]}, {"Citation": "Zhang C., Chen J., Feng C., Shao X., Liu Q., Zhang Q., et al. (2014). Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer\u2019s disease. Intern. J. Pharm. 461 192\u2013202. 10.1016/j.ijpharm.2013.11.049", "ArticleIdList": ["10.1016/j.ijpharm.2013.11.049", "24300213"]}, {"Citation": "Zhang J., Zhou X., Yu Q., Yang L., Sun D., Zhou Y., et al. (2014). Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-\u03b2 aggregation and cytotoxicity. ACS Appl. Mater. Interf. 6 8475\u20138487. 10.1021/am501341u", "ArticleIdList": ["10.1021/am501341u", "24758520"]}, {"Citation": "Zhang M., Zang X., Wang M., Li Z., Qiao M., Hu H., et al. (2019). Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges. J. Mater. Chem. B 7 2421\u20132433. 10.1039/c9tb00170k", "ArticleIdList": ["10.1039/c9tb00170k", "32255119"]}, {"Citation": "Zhao G., Dong X., Sun Y. (2018). Self-assembled curcumin\u2013poly (carboxybetaine methacrylate) conjugates: potent nano-inhibitors against amyloid \u03b2-protein fibrillogenesis and cytotoxicity. Langmuir 35 1846\u20131857. 10.1021/acs.langmuir.8b01921", "ArticleIdList": ["10.1021/acs.langmuir.8b01921", "30134656"]}, {"Citation": "Zheng W., Wei M., Li S., Le W. (2016). Nanomaterial-modulated autophagy: underlying mechanisms and functional consequences. Nanomedicine 11 1417\u20131430. 10.2217/nnm-2016-0040", "ArticleIdList": ["10.2217/nnm-2016-0040", "27193191"]}, {"Citation": "Zhou X., Sun J., Yin T., Le F., Yang L., Liu Y., et al. (2015). Enantiomers of cysteine-modified SeNPs (d/l SeNPs) as inhibitors of metal-induced A\u03b2 aggregation in Alzheimer\u2019s disease. J. Mater. Chem. B 3 7764\u20137774. 10.1039/c5tb00731c", "ArticleIdList": ["10.1039/c5tb00731c", "32264585"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "2"}, {"Year": "2020", "Month": "3", "Day": "9"}, {"Year": "2020", "Month": "4", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32318551", "PMC7154137", "10.3389/fbioe.2020.00238"]}}]}